These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34921433)

  • 1. Influence of baseline QTc on sotalol-induced prolongation of ventricular repolarization in men and women.
    Funck-Brentano C; Salem JE
    Br J Clin Pharmacol; 2022 Jul; 88(7):3510-3515. PubMed ID: 34921433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.
    Darpo B; Karnad DR; Badilini F; Florian J; Garnett CE; Kothari S; Panicker GK; Sarapa N
    Br J Clin Pharmacol; 2014 Mar; 77(3):522-31. PubMed ID: 23819796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.
    Salem JE; Dureau P; Bachelot A; Germain M; Voiriot P; Lebourgeois B; Trégouët DA; Hulot JS; Funck-Brentano C
    JAMA Cardiol; 2018 Sep; 3(9):877-882. PubMed ID: 30073300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
    Démolis JL; Strabach S; Vacheron F; Funck-Brentano C
    Br J Clin Pharmacol; 2005 Aug; 60(2):120-7. PubMed ID: 16042664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT variability during initial exposure to sotalol: experience based on a large electronic medical record.
    Weeke P; Delaney J; Mosley JD; Wells Q; Van Driest S; Norris K; Kucera G; Stubblefield T; Roden DM
    Europace; 2013 Dec; 15(12):1791-7. PubMed ID: 23787903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in cardiac repolarization following intravenous sotalol administration.
    Somberg JC; Preston RA; Ranade V; Cvetanovic I; Molnar J
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):86-92. PubMed ID: 21527783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction.
    Huang CY; Overholser BR; Sowinski KM; Jaynes HA; Kovacs RJ; Tisdale JE
    PLoS One; 2024; 19(8):e0308999. PubMed ID: 39159176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers.
    Kannankeril PJ; Norris KJ; Carter S; Roden DM
    Heart Rhythm; 2011 Oct; 8(10):1530-4. PubMed ID: 21420510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology.
    Graff C; Andersen MP; Xue JQ; Hardahl TB; Kanters JK; Toft E; Christiansen M; Jensen HK; Struijk JJ
    Drug Saf; 2009; 32(7):599-611. PubMed ID: 19530746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
    Agusala K; Oesterle A; Kulkarni C; Caprio T; Subacius H; Passman R
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):490-8. PubMed ID: 25626340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats.
    Özgür Barış V; Dinçsoy B; Gedikli E; Erdemb A
    Kardiol Pol; 2021 Jan; 79(1):53-57. PubMed ID: 33146500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JTc prolongation with d,l-sotalol in women versus men.
    Lehmann MH; Hardy S; Archibald D; MacNeil DJ
    Am J Cardiol; 1999 Feb; 83(3):354-9. PubMed ID: 10072223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diseases and drugs causing prolongation of the QT interval.
    Laakso M; Aberg A; Savola J; Pentikäinen PJ; Pyörälä K
    Am J Cardiol; 1987 Apr; 59(8):862-5. PubMed ID: 3825950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.
    Ting C; Malloy R; Knowles D
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):438-443. PubMed ID: 32347108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.
    Derakhchan K; Chui RW; Stevens D; Gu W; Vargas HM
    Br J Pharmacol; 2014 Jan; 171(2):509-22. PubMed ID: 24372552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not-in-trial simulation I: Bridging cardiovascular risk from clinical trials to real-life conditions.
    Chain AS; Dieleman JP; van Noord C; Hofman A; Stricker BH; Danhof M; Sturkenboom MC; Della Pasqua O
    Br J Clin Pharmacol; 2013 Dec; 76(6):964-72. PubMed ID: 23617533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QTc compared to JTc for monitoring drug-induced repolarization changes in the setting of ventricular pacing.
    Tsai SF; Houmsse M; Dakhil B; Augostini R; Hummel JD; Kalbfleisch SJ; Liu Z; Love C; Rhodes T; Tyler J; Weiss R; Hamam I; Winner M; Daoud EG
    Heart Rhythm; 2014 Mar; 11(3):485-91. PubMed ID: 24252288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.